Adjuvant Embolization With N-Butyl Cyanoacrylate in the Treatment of Cerebral Arteriovenous Malformations Outcomes, Complications, and Predictors of Neurologic Deficits

被引:75
|
作者
Starke, Robert M.
Komotar, Ricardo J.
Otten, Marc L.
Hahn, David K. [2 ]
Fischer, Laura E.
Hwang, Brian Y.
Garrett, Matthew C.
Sciacca, Robert R.
Sisti, Michael B.
Solomon, Robert A.
Lavine, Sean D. [3 ]
Connolly, E. Sander
Meyers, Philip M. [1 ,3 ]
机构
[1] Columbia Univ, Dept Neurosurg, Neurol Inst, New York, NY 10032 USA
[2] Northwestern Univ, Dept Neurosurg, Chicago, IL 60611 USA
[3] Columbia Univ, Dept Intervent Neuroradiol, New York, NY 10032 USA
关键词
arteriovenous malformation; complication; embolization; outcome; surgery; PREOPERATIVE EMBOLIZATION; ENDOVASCULAR TREATMENT; GRADING SYSTEM; STEREOTAXIC RADIOSURGERY; SURGICAL-MANAGEMENT; BASAL GANGLIA; BRAIN; EXPERIENCE; DETERMINANTS; SURGERY;
D O I
10.1161/STROKEAHA.108.539775
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The purpose of this study was to assess the frequency, severity, and predictors of neurological deficits after adjuvant embolization for cerebral arteriovenous malformations. Methods-From 1997 to 2006, 202 of 275 patients with arteriovenous malformation received embolization before microsurgery (n = 176) or radiosurgery (n = 26). Patients were examined before and after endovascular embolization and at clinical follow-up (mean, 43.4 +/- 34.6 months). Outcome was classified according to the modified Rankin Scale. New neurological deficits after embolization were defined as minimal (no change in overall modified Rankin Scale), moderate (modified Rankin Scale <= 2), or significant (modified Rankin Scale > 2). Results-Two hundred two patients were treated in 377 embolization procedures. There were a total of 29 new clinical deficits after embolization (8% of procedures; 14% of patients), of which 19 were moderate or significant. Postembolization deficits resolved in a significant number of patients over time (P < 0.0001). Five patients had persistent neurological deficits due to embolization (1.3% of procedures; 2.5% of patients). In multivariate analysis, the following variables significantly predicted new neurological deficit after embolization: complex arteriovenous malformation with treatment plan specifying more than one embolization procedure (OR, 2.7; 95% CI, 1.4 to 8.6), diameter < 3 cm (OR, 3.2; 95% CI, 1.2 to 9.1), diameter > 6 cm (OR, 6.2; 95% CI, 1.0 to 57.0), deep venous drainage (OR, 2.7; 95% CI, 1.1 to 6.9), or eloquent location (OR, 2.4; 95% CI, 1.0 to 5.7). These variables were weighted and used to compute an arteriovenous malformation Embolization Prognostic Risk Score for each patient. A score of 0 predicted no new deficits, a score of 1 predicted a new deficit rate of 6%, a score of 2 predicted a new deficit rate of 15%, a score of 3 predicted a new deficit rate of 21%, and a score of 4 predicted a new deficit rate of 50% (P < 0.0001). Conclusions-Small and large size, eloquent location, deep venous drainage, and complex vascular anatomy requiring multiple embolization procedures are risk factors for the development of immediate postembolization neurological deficits. Nevertheless, a significant number of patients with treatment-related neurological deficits improve over time. The low incidence of permanent neurological deficits underscores the usefulness of this technique in carefully selected patients. (Stroke. 2009; 40: 2783-2790.)
引用
收藏
页码:2783 / 2790
页数:8
相关论文
共 50 条
  • [21] Comparison of N-butyl cyanoacrylate and Onyx for the embolization of intracranial arteriovenous malformations:: Analysis of fluoroscopy and procedure times
    Velat, Gregory J.
    Reavey-Cantwell, John F.
    Sistrom, Christopher
    Smullen, David
    Fautheree, Gregory L.
    Whiting, Jobyna
    Lewis, Stephen B.
    Mericle, Robert A.
    Firment, Christopher S.
    Hoh, Brian L.
    NEUROSURGERY, 2008, 63 (01) : 73 - 78
  • [22] Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations
    Kitagawa, Akira
    Izumi, Yuichiro
    Hagihara, Makiyo
    Kamei, Seiji
    Ikeda, Shuji
    Katsuda, Eisuke
    Kimura, Junko
    Ota, Toyohiro
    Ishiguchi, Tsuneo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2014, 37 (02) : 371 - 380
  • [23] Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate Laboratory investigation
    Natarajan, Sabareesh Kumar
    Born, Donald
    Ghodke, Basavaraj
    Britz, Gavin W.
    Sekhar, Laligam N.
    JOURNAL OF NEUROSURGERY, 2009, 111 (01) : 105 - 113
  • [24] Erratum to: Ethanolamine Oleate Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations
    Akira Kitagawa
    Yuichiro Izumi
    Makiyo Hagihara
    Seiji Kamei
    Shuji Ikeda
    Eisuke Katsuda
    Junko Kimura
    Toyohiro Ota
    Tsuneo Ishiguchi
    CardioVascular and Interventional Radiology, 2014, 37 (1) : 284 - 285
  • [25] Comparison of N-butyl cyanoacrylate and Onyx for the embolization of intracranial arteriovenous malformations:: Analysis of fluoroscopy and procedure times -: Comments
    Albuquerque, Felipe C.
    Rosenwasser, Robert H.
    Hage, Ziad A.
    Bendok, Bernard R.
    Boulos, Alan S.
    Moskowitz, Shaye
    Rasmussen, Peter A.
    Yamamoto, Junichi
    Hopkins, L. Nelson
    NEUROSURGERY, 2008, 63 (01) : 78 - 80
  • [26] N-butyl 2-cyanoacrylate embolization of spinal dural arteriovenous fistulae
    Song, JK
    Gobin, YP
    Duckwiler, GR
    Murayama, Y
    Frazee, JG
    Martin, NA
    Viñuela, F
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2001, 22 (01) : 40 - 47
  • [27] Complication analysis of 469 brain arteriovenous malformations treated with N-butyl cyanoacrylate
    Li, TL
    Fang, B
    He, XY
    Duan, CZ
    Wang, QJ
    Zhao, OP
    Huan, QYF
    INTERVENTIONAL NEURORADIOLOGY, 2005, 11 (02) : 141 - 148
  • [28] Single-stage embolization with n-butyl cyanoacrylate and surgical resection of venous malformations
    Polites, Stephanie F.
    Watanabe, Miho
    Scorletti, Federico
    Patel, Manish N.
    Ricci, Kiersten W.
    Hammill, Adrienne M.
    Dasgupta, Roshni
    PEDIATRIC BLOOD & CANCER, 2020, 67 (03)
  • [29] Acute spontaneous hemorrhage after embolization of brain arteriovenous malformation with N-butyl cyanoacrylate
    Picard, L
    Da Costa, E
    Anxionnat, R
    Macho, J
    Bracard, S
    Per, A
    Marchal, JC
    JOURNAL OF NEURORADIOLOGY, 2001, 28 (03) : 147 - 165
  • [30] Penetration difference of N-butyl 2-cyanoacrylate in the embolization of brain arteriovenous malformation
    Suh, DC
    Park, S
    Kim, J
    Choi, CG
    Lee, HK
    Song, H
    RADIOLOGY, 1996, 201 : 584 - 584